The current valuation score of Telomir Pharmaceuticals Inc is 6.83, ranking 144 out of 156 in the Pharmaceuticals industry. Its current P/E ratio is -3.83, which is -45.12% below the recent high of -2.10 and -548.92% above the recent low of -24.86.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.